Hirudin as a novel fusion tag for efficient production of lunasin in Escherichia coli.

Prep Biochem Biotechnol

a Department of Molecular Biology, State Key Laboratory of Natural Medicines, School of Life Science and Technology , China Pharmaceutical University, Nanjing , P.R. China.

Published: July 2017


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Fusion expression provides an effective means for the biosynthesis of longer peptides in Escherichia coli. However, the commonly used fusion tags are primarily suitable for laboratory scale applications due to the high cost of commercial affinity resins. Herein, a novel approach exploiting hirudin as a multipurpose fusion tag in combination with tobacco etch virus (TEV) protease cleavage has been developed for the efficient and cost-effective production of a 43-amino acid model peptide lunasin in E. coli at preparative scale. A fusion gene which allows for lunasin to be N-terminally fused to the C-terminus of hirudin through a flexible linker comprising a TEV protease cleavage site was designed and cloned in a secretion vector pTASH. By cultivation in a 7-L bioreactor, the fusion protein was excreted into the culture medium at a high yield of ~380 mg/L, which was conveniently recovered and purified by inexpensive HP20 hydrophobic chromatography at a recovery rate of ~80%. After polishing and cleavage with TEV protease, the finally purified lunasin was obtained with ≥95% purity and yield of ~86 mg/L culture medium. Conclusively, this hirudin tagging strategy is powerful in the production of lunasin and could be applicable for the production of other peptides at preparative scale.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10826068.2017.1286600DOI Listing

Publication Analysis

Top Keywords

tev protease
12
fusion tag
8
production lunasin
8
escherichia coli
8
protease cleavage
8
preparative scale
8
culture medium
8
fusion
6
lunasin
5
hirudin
4

Similar Publications

The adhesion G protein-coupled receptor ADGRE5/CD97 is upregulated in many cancers, representing a potential drug target in oncology/immuno-oncology. Yet, ADGRE5's activation and signaling mechanisms remain poorly understood. Here, we used enhanced bystander bioluminescence resonance energy transfer (ebBRET)-based biosensors and three strategies to characterize human (h) ADGRE5 signaling.

View Article and Find Full Text PDF

Protein tags are vital in biochemical engineering but must be removed from target molecules to prevent compromising effects. Most industrial applications use Tobacco Etch Virus protease (TEVp) for this purpose. However, selectivity at the P1' position of its recognition site requires N-terminal addition of glycine or serine to noncanonical targets.

View Article and Find Full Text PDF

Cyclization is a promising strategy to enhance protein stability, but its applicability is often limited by structural constraints such as the distance between the N- and C-terminal regions. Here, we report the rational design and characterization of a cyclized Tobacco Etch Virus protease (cTEVp) using the SpyRing system, which enables covalent cyclization through SpyTag/SpyCatcher-mediated isopeptide bond formation. We applied this approach to a widely used engineered TEVp variant (L56V, S135G, S219V, Δ238-242) and employed AlphaFold structure prediction to optimize linker length and domain positioning.

View Article and Find Full Text PDF

Methods for monitoring physiological changes in cellular Ca levels have been in high demand for their utility in monitoring neuronal signaling. Recently, we introduced SCANR (Split-Tobacco Etch Virus (TEV) protease Calcium-regulated Neuron Recorder), which reports on Ca changes in cells through the binding of calmodulin and M13 to reconstitute an active TEV protease. First-generation SCANR marked all of the Ca spikes that occur throughout the lifetime of the cell, but it did not have a mechanism for controlling the time window in which recording of physiological changes in Ca occurred.

View Article and Find Full Text PDF

Scalable production of functional recombinant human plasma gelsolin in Escherichia coli for therapeutic and diagnostic applications.

Protein Expr Purif

November 2025

Biotechnology Process Engineering Center, KRIBB, Cheongju, 20736, Republic of Korea; Department of Biosystems and Bioengineering, KRIBB School of Biotechnology, Korea University of Science and Technology (UST), 217 Gajeong-ro, Yuseong-gu, Daejeon, Republic of Korea. Electronic address:

Human plasma gelsolin (pGSN) is an 83 kDa actin-binding protein involved in cytoskeletal remodeling, inflammation, and host defense. Its clinical relevance as a biomarker and potential therapeutic agent, particularly in conditions like sepsis, acute respiratory distress syndrome (ARDS), and cystic fibrosis, has driven interest in scalable recombinant expression. However, high-yield production of functionally active gelsolin is hindered by its complex structure and folding requirements.

View Article and Find Full Text PDF